Theodore T. Wang is Director & 10% Owner at Bellerophon Therapeutics, Inc. (BLPH). They have made 6 open-market trades across 1 company since 2019, most recently 2023-06-29.
CIK 0001694061
6 open-market purchases totalling $553K since 2019, never a sale. Across 6 scored buys the stock is down 4.1% at ninety days, and 8.6 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 33% |
| Avg Move | -0.8% | -1.6% | -4.1% |
| Alpha | -0.8% | -4.7% | -8.6% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLPH | BUY | 2020-06-05 | 2020-06-09 | $12.75 | $160K | -1.6% | -3.6% | -31.3% |
| BLPH | BUY | 2019-11-21 | 2019-11-25 | $0.39 | $3K | +8.4% | -6.6% | +30.5% |
| BLPH | BUY | 2019-06-12 | 2019-06-14 | $0.64 | $32K | -2.7% | -2.1% | -9.4% |
| BLPH | BUY | 2019-05-22 | 2019-05-24 | $0.60 | $17K | -7.6% | +0.0% | -4.7% |
| BLPH | BUY | 2019-05-21 | 2019-05-22 | $0.61 | $26K | +0.3% | +7.7% | +2.0% |
| BLPH | BUY | 2019-01-25 | 2019-01-25 | $0.70 | $315K | -1.9% | -5.1% | -11.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.